经典骨髓增殖性瘤的分子管理
Charlène G S Soro1,2, Sara Benchikh3,4, Adil El Hamouchi4
1Biology and Health Laboratory (LBS) -URAC 34, Faculty of Sciences Ben M'Sik, Hassan II University, Casablanca, Morocco. georgina.soro-etu@etu.univh2c.ma.
Journal of the Egyptian National Cancer Institute
|November 10, 2025
概括
分子检查对于诊断骨髓增殖性瘤 (MPNs) 是至关重要的. 虽然下一代测序 (NGS) 是先进的,但像qPCR这样的经济有效的替代方案对于低资源的环境至关重要.
科学领域:
- 血液学 血液学 血液学
- 基因组学就是基因组学.
- 在瘤学瘤学.
背景情况:
- 骨髓增殖性瘤 (MPNs) 与造血干细胞的基因组变化有关.
- 世界卫生组织 (WHO) 的指导方针建议对MPN诊断和管理进行分子调查.
- 下一代测序 (NGS) 已经为瘤异常检测提供了先进的分析平台.
研究的目的:
- 提供有关MPN分类的最新审查.
- 检查MPN诊断的当代分析技术.
- 强调各种诊断方法的优缺点.
主要方法:
- 在PubMed和Science Direct数据库中进行文献搜索.
- 综合科学文献进行审查.
- 使用Excel 2016软件编译数据.
主要成果:
- 在MPN中驱动突变可以通过基因定型或测序来识别.
- 基因造型具有较低的灵敏度,增加了虚假阴性.
- 测序更敏感,但可能具有特定性或时间限制.
结论:
- 虽然NGS得到了广泛的支持,但对于低收入和中等收入地区来说,成本效益至关重要.
- 实时聚合酶连锁反应 (qPCR),免疫组织化学 (CAL2IHC) 和dHPLC等替代技术需要探索.
- 为了更广泛的可访问性,需要可持续的诊断选择.
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.9K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.9K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Bone Marrow Sampling and Transplants
846
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
846
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


